I. Gutierro

Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres

I. Gutierro, Rosa Marı́a Hernández, M. Igartua et al. · Vaccine · 2002 · 285 citations

Nanoparticles, Nanomedicine, Intranasal Administration +8

Influence of dose and immunization route on the serum Ig G antibody response to BSA loaded PLGA microspheres

I. Gutierro, Rosa Marı́a Hernández, M. Igartua et al. · Vaccine · 2002 · 43 citations

Immunohematology, Immunocytochemical Technique, Allergy +11

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose strengths in patients with schizophrenia or schizoaffective disorder (PRISMA-1)

Jordi Llaudó, Lourdes Anta, I. Ayani et al. · International Clinical Psychopharmacology · 2016 · 24 citations

Drug Safety, Therapeutic Drug Monitoring, Dose Administration +12

A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia

L. Anta Carabias, Jordi Llaudó, I. Ayani et al. · International Clinical Psychopharmacology · 2017 · 21 citations

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study

David P. Walling, Howard A Hassman, Lourdes Anta et al. · Drug Design Development and Therapy · 2021 · 16 citations · Full text